APLS - Apellis Pharmaceuticals, Inc.

QQQ $ 443.87 $ -0.91 (-0.2 %)

DIA $ 394.42 $ -0.67 (-0.17 %)

SPY $ 521.25 $ -0.93 (-0.18 %)

TLT $ 90.49 $ -0.13 (-0.14 %)

GLD $ 217.54 $ -0.30 (-0.14 %)

Previous Close

$ 43.01

Open

$ 42.83

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 41.50 - $ 42.83

52 Week Range

$ 19.83 - $ 94.75

Volume

1,153,471

Average Volume

Market Cap

5.29B

Beta (5Y Monthly)

$ 0.91

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-27-2024	12-31-2023	10-K
3	11-01-2023	09-30-2023	10-Q
4	07-31-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-21-2023	12-31-2022	10-K
7	11-07-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	04-28-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-02-2020	09-30-2020	10-Q
16	07-30-2020	06-30-2020	10-Q
17	04-29-2020	03-31-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	07-31-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	02-26-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	07-31-2018	06-30-2018	10-Q
25	04-30-2018	03-31-2018	10-Q
26	03-19-2018	12-31-2017	10-K
27	12-20-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Apellis Pharmaceuticals Refinances Existin...
05/14/2024 12:30:09

Apellis received $375 million in funding at close, with ability to access an additional $100 millionMajority of initial proceed...

Citigroup Maintains Buy on Apellis Pharmac...
05/08/2024 19:34:29

Citigroup analyst Yigal Nochomovitz maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and lowers the price target f...

HC Wainwright & Co. Reiterates Buy on Apel...
05/08/2024 19:08:49

HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $92 p...

In-Depth Examination Of 14 Analyst Recomme...
05/08/2024 18:00:15

UBS Maintains Buy on Apellis Pharmaceutica...
05/08/2024 13:14:20

UBS analyst Eliana Merle maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and lowers the price target from $89 to ...

Needham Reiterates Buy on Apellis Pharmace...
05/08/2024 09:45:19

Needham analyst Joseph Stringer reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $85 price target.

Apellis Pharmaceuticals Q1 EPS $(0.54) Mis...
05/07/2024 11:10:34

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimat...

Mizuho Maintains Neutral on Apellis Pharma...
04/29/2024 11:34:46

Mizuho analyst Graig Suvannavejh maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and lowers the price target ...

HC Wainwright & Co. Reiterates Buy on Apel...
04/26/2024 18:22:23

HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $92 p...

European Medicines Agency Has Reset The Re...
04/26/2024 11:19:34

Needham Reiterates Buy on Apellis Pharmace...
04/25/2024 17:15:07

Needham analyst Joseph Stringer reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $85 price target.

Wedbush Maintains Neutral on Apellis Pharm...
04/17/2024 16:26:41

Wedbush analyst Laura Chico maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and lowers the price target from ...

Expert Ratings For Apellis Pharmaceuticals
04/15/2024 14:00:43

HC Wainwright & Co. Reiterates Buy on Apel...
04/15/2024 11:07:14

HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $92 p...

if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-3000-today

If You Invested $1000 In This Stock 5 Year...
04/10/2024 19:00:26

Needham Reiterates Buy on Apellis Pharmace...
04/09/2024 10:26:51

Needham analyst Joseph Stringer reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $85 price target.

1000-invested-in-this-stock-5-years-ago-would-be-worth-3000-today

$1000 Invested In This Stock 5 Years Ago W...
03/29/2024 21:00:22

Decoding 15 Analyst Evaluations For Apelli...
03/27/2024 18:01:31

Mizuho Maintains Neutral on Apellis Pharma...
03/27/2024 17:18:02

Mizuho analyst Graig Suvannavejh maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and maintains $60 price target.

peering-into-apellis-pharmaceuticalss-recent-short-interest

Peering Into Apellis Pharmaceuticals's Rec...
03/15/2024 13:15:13